Aligos Therapeutics, Inc. - COM (ALGS)

Historical Portfolio Holders from Q4 2020 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
47.3M
Holdings value Q2 2024
$16.6M
Value change Q2 2024
-$1.53M
Grand Portfolio weight change Q2 2024
0%
Number of holders
46
Number of buys Q2 2024
18
Number of sells Q2 2024
-22
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 0 $0 -$35 0
2024 Q2 47.3M $16.6M -$1.53M $0.35 46
2024 Q1 46.2M $45.3M +$1.76M $0.98 49
2023 Q4 45.3M $30.1M +$11M $0.66 38
2023 Q3 25.7M $19.2M -$456K $0.75 35
2023 Q2 26.3M $25.5M -$906K $0.97 41
2023 Q1 27.3M $23.9M +$714K $0.87 44
2022 Q4 26.5M $25.3M -$1.39M $0.95 37
2022 Q3 27.6M $30.4M -$2.58M $1.10 46
2022 Q2 29.8M $36M -$6.05M $1.21 53
2022 Q1 31.7M $68.2M -$40.1M $2.15 73
2021 Q4 32.9M $390M +$18.5M $11.87 68
2021 Q3 31.2M $484M +$61.7M $15.51 67
2021 Q2 27M $550M -$555K $20.39 55
2021 Q1 27M $612M -$9.66M $22.74 50
2020 Q4 27.3M $749M +$725M $27.65 50